Czechia considers that Antifoam B should not be considered as a substance of concern as defined in Article 3(1), point (f), of Regulation (EU) No 528/2012, since its constituent octamethylcyclotetrasiloxane is present in the product in a very low concentration (0,0025-0,015 % (w/w)) and it was not identified as PBT and vPvB by the Agency at the time of submission of the application for renewal of the authorisation of the product.
Recital 6, Decision_act (EU) 2024/1305
In forcesince 8 May 2024